Literature DB >> 10650676

The outcomes of an inpatient treatment program for geriatric patients with dementia and dysfunctional behaviors.

A Holm1, M Michel, G A Stern, T M Hung, T Klein, L Flaherty, S Michel, G Maletta.   

Abstract

This study evaluated outcomes of an inpatient program designed to reduce severe agitated behavior in geriatric patients with dementia who could not be successfully treated on an outpatient basis. An individualized treatment plan was created for each patient (N = 250) that involved pharmacological and nonpharmacological interventions with behavioral, environmental, and psychological components. Assessment of behavioral, cognitive, and functional status was conducted for each patient on admission to the program and at discharge. Significant improvements on these assessments were observed. We conclude that the longitudinal, multidisciplinary approach used in this study was effective in significantly reducing intrusive and dangerous behaviors while preserving or enhancing patients' cognitive and functional abilities.

Entities:  

Mesh:

Year:  1999        PMID: 10650676     DOI: 10.1093/geront/39.6.668

Source DB:  PubMed          Journal:  Gerontologist        ISSN: 0016-9013


  4 in total

1.  Geriatric patients with cognitive impairment.

Authors:  Wolfgang von Renteln-Kruse; Lilli Neumann; Björn Klugmann; Andreas Liebetrau; Stefan Golgert; Ulrike Dapp; Birgit Frilling
Journal:  Dtsch Arztebl Int       Date:  2015-02-13       Impact factor: 5.594

2.  A 6-month, randomized, double-blind, placebo-controlled pilot discontinuation trial following response to haloperidol treatment of psychosis and agitation in Alzheimer's disease.

Authors:  D P Devanand; Gregory H Pelton; Karine Cunqueiro; Harold A Sackeim; Karen Marder
Journal:  Int J Geriatr Psychiatry       Date:  2010-12-28       Impact factor: 3.485

3.  The antipsychotic discontinuation in Alzheimer disease trial: clinical rationale and study design.

Authors:  D P Devanand; Jacobo Mintzer; Susan Schultz; David Sultzer; Danilo de la Pena; Sanjay Gupta; Sylvia Colon; Corbett Schimming; Gregory H Pelton; Howard Andrews; Bruce Levin
Journal:  Am J Geriatr Psychiatry       Date:  2012-04       Impact factor: 4.105

4.  Relapse risk after discontinuation of risperidone in Alzheimer's disease.

Authors:  D P Devanand; Jacobo Mintzer; Susan K Schultz; Howard F Andrews; David L Sultzer; Danilo de la Pena; Sanjay Gupta; Sylvia Colon; Corbett Schimming; Gregory H Pelton; Bruce Levin
Journal:  N Engl J Med       Date:  2012-10-18       Impact factor: 91.245

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.